U.S pharmaceutical giant Pfizer and German biotech firm BioNTech said their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, according to data published Monday from their late-stage vaccine trial. Pfizer CEO Albert Bourla explains the company's plan to roll out the vaccine to meet the high demand.